SCHEMBL26065616

SCHEMBL26065616

O=S(=O)(c1ccc(C(F)(F)F)nc1C(F)(F)F)N1CCN(CC2COC2)CC1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.37
TPSAB1 Q15661 1/20 0.37
MEN1 O00255 1/20 0.37
KCNH2 Q12809 1/20 0.37
TRPV4 Q9HBA0 1/20 0.36
POLB P06746 1/20 0.36
ALDH1A1 P00352 4/20 0.36
KDM4E B2RXH2 4/20 0.36
TDP1 Q9NUW8 2/20 0.36
HPGD P15428 1/20 0.36
RECQL P46063 1/20 0.36
CYP3A4 P08684 1/20 0.35
GAA P10253 1/20 0.35
CYP2D6 P10635 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
KDM2B Q8NHM5 1/20 0.35
TSHR P16473 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26065891 0.89 TRPV4 (0.41) KMT2ATPSAB1MEN1KCNH2TRPV4
SCHEMBL26066147 0.87 KCNH2 (0.42) KMT2ATPSAB1MEN1KCNH2POLB
SCHEMBL25369955 0.87 TRPV4 (0.38) TRPV4
SCHEMBL26065920 0.82 EBP (0.39) KMT2ATPSAB1MEN1KCNH2TRPV4
SCHEMBL26065919 0.82 EBP (0.39) KMT2ATPSAB1MEN1KCNH2TRPV4
SCHEMBL26065762 0.82 EBP (0.39) KMT2ATPSAB1MEN1KCNH2TRPV4
SCHEMBL26065774 0.80 TLR7 (0.42) KMT2ATPSAB1MEN1KCNH2TRPV4
SCHEMBL26065889 0.79 EBP (0.44) TPSAB1KCNH2TRPV4KDM2B
SCHEMBL26066067 0.78 KCNH2 (0.43) TPSAB1KCNH2
SCHEMBL26065535 0.78 MEN1 (0.42) KMT2AMEN1TRPV4ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023164063-A1 EMOPAMIL-BINDING PROTEIN INHIBITORS AND USES THEREOF BIOGEN MA INC. (US) 2023-08-31 WO disclosed